Key Events This Week
3 Aug: Stock opens at Rs.483.75 with a 0.97% gain
4 Aug: Golden Cross formation and Mojo Grade upgraded to Buy
5 Aug: Intraday high surge of 7.34% to Rs.531
6 Aug: Continued gains with Rs.531.75 close (+1.69%)
7 Aug: Week closes at Rs.546.40 (+2.76%)
3 August 2026: Positive Start Amid Broad Market Gains
Dr Agarwals Health Care Ltd began the week on a positive note, closing at Rs.483.75, up 0.97% from the previous Friday’s close of Rs.479.10. This gain slightly outpaced the Sensex’s 0.82% rise to 36,985.17 points. The stock’s volume was modest at 4,815 shares, indicating cautious but steady buying interest. The initial uptick set the tone for the week’s bullish momentum.
4 August 2026: Golden Cross Formation and Mojo Grade Upgrade
The stock gained further traction on 4 August, rising 1.86% to close at Rs.492.75 despite the Sensex slipping 0.14% to 36,933.47. This day marked a significant technical milestone as Dr Agarwals Health Care Ltd formed a Golden Cross, where the 50-day moving average crossed above the 200-day moving average, signalling a potential bullish breakout and a shift in long-term momentum.
Alongside this technical development, MarketsMOJO upgraded the company’s Mojo Grade from Hold to Buy, reflecting improved technical indicators, strong quarterly financial results, and a positive outlook. The upgrade was supported by a Mojo Score of 72.0, underscoring the stock’s enhanced quality and trend strength.
Volume surged to 17,060 shares, indicating increased investor interest following these positive signals. The Golden Cross and rating upgrade together provided a compelling case for renewed buying enthusiasm.
5 August 2026: Intraday High Surge Amid Mixed Market Conditions
On 5 August, Dr Agarwals Health Care Ltd demonstrated robust intraday strength, surging 7.34% to an intraday high of Rs.531. The stock closed at Rs.522.90, a 6.12% gain on the day, significantly outperforming the Sensex which rose a modest 0.38% to 37,074.66. This marked the third consecutive day of gains, with the stock appreciating 10.83% over this period.
Technical indicators remained bullish, with the stock trading comfortably above key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The daily moving averages and weekly MACD supported the positive momentum, while the KST oscillator and Bollinger Bands on weekly charts indicated sustained upward pressure.
Volume peaked at 34,829 shares, reflecting strong market participation and confirming the bullish trend. The stock’s performance contrasted with the broader market’s volatility, as the Sensex closed marginally lower by 0.08% after an intraday reversal.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
6 August 2026: Continued Gains with Positive Technical Momentum
The bullish trend extended into 6 August, with the stock closing at Rs.531.75, up 1.69% on the day. The Sensex also advanced 0.28% to 37,177.57, but the stock’s outperformance remained clear. Volume was strong at 28,067 shares, supporting the sustained buying interest.
Technical momentum remained positive, with daily moving averages bullish and weekly MACD and Bollinger Bands signalling continued upward pressure. The Dow Theory assessment was mildly bullish, reinforcing the view of a strengthening trend. The stock’s proximity to its 52-week high of Rs.567.80 suggested room for further appreciation.
7 August 2026: Week Closes Strong Despite Sensex Dip
Dr Agarwals Health Care Ltd closed the week at Rs.546.40, gaining 2.76% on 7 August despite the Sensex retreating 0.21% to 37,099.57. Volume moderated to 8,727 shares, but the stock’s weekly gains of 14.05% clearly outpaced the Sensex’s 1.13% rise, highlighting strong relative strength.
The stock’s technical indicators remained supportive, with bullish daily moving averages and positive weekly momentum. The upgrade to a Buy rating and strong quarterly financials underpinned investor confidence, while the stock’s valuation metrics, though premium, reflected growth expectations.
Thinking about Dr Agarwals Health Care Ltd? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this small-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-08-03 | Rs.483.75 | +0.97% | 36,985.17 | +0.82% |
| 2026-08-04 | Rs.492.75 | +1.86% | 36,933.47 | -0.14% |
| 2026-08-05 | Rs.522.90 | +6.12% | 37,074.66 | +0.38% |
| 2026-08-06 | Rs.531.75 | +1.69% | 37,177.57 | +0.28% |
| 2026-08-07 | Rs.546.40 | +2.76% | 37,099.57 | -0.21% |
Key Takeaways from the Week
Strong Outperformance: Dr Agarwals Health Care Ltd’s 14.05% weekly gain far exceeded the Sensex’s 1.13%, highlighting robust relative strength amid mixed broader market conditions.
Technical Breakthrough: The Golden Cross formation on 4 August marked a pivotal technical signal, confirmed by bullish daily and weekly indicators including MACD, Bollinger Bands, and KST oscillator.
Rating Upgrade: MarketsMOJO’s upgrade from Hold to Buy, supported by a Mojo Score of 72.0, reflected improved technical and fundamental metrics, boosting investor confidence.
Robust Financials: Strong Q1 FY27 results with record net sales and profitability underscored the company’s operational strength and growth trajectory.
Volume Confirmation: Elevated trading volumes on key days, especially 4 and 5 August, validated the price gains and indicated genuine buying interest.
Valuation Caution: Despite positive momentum, the stock’s premium valuation metrics, including a high P/E ratio and EV/Capital Employed, suggest investors should monitor earnings delivery closely.
Conclusion: A Week Marked by Bullish Momentum and Upgraded Outlook
Dr Agarwals Health Care Ltd’s performance during the week of 3 to 7 August 2026 was characterised by strong gains, technical breakthroughs, and an upgraded analyst rating. The Golden Cross formation and subsequent Mojo Grade upgrade to Buy signalled a shift in momentum, supported by robust quarterly financial results and sustained buying interest.
The stock’s 14.05% rise significantly outpaced the Sensex, reflecting its resilience and appeal within the hospital sector. While valuation metrics remain elevated, the combination of positive technical indicators and fundamental strength provides a compelling narrative for the stock’s near-term trajectory.
Investors should continue to monitor volume trends and earnings updates to confirm the durability of this bullish phase. Overall, the week marked a notable turning point for Dr Agarwals Health Care Ltd, positioning it favourably within its sector and the broader market.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
